Endometrial pathology at dilatation and curettage in breast cancer patients: Comparison of tamoxifen users and nonusers

Cancer Journal from Scientific American

Volumn 2, Issue 1, 1996, Pages 35-38

  Gibson, L E ^a   Barakat, R R ^a   Venkatraman, E S ^a   Hoskins, W J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Breast carcinoma; Endometrial neoplasm; Tamoxifen

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; TAMOXIFEN;

ADENOCARCINOMA; ARTICLE; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; CURETTAGE; DRUG EFFECT; ENDOMETRIUM; FEMALE; HUMAN; HYPERPLASIA; MIDDLE AGED; PATHOLOGY; POLYP; RETROSPECTIVE STUDY;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; DILATATION AND CURETTAGE; ENDOMETRIUM; FEMALE; HUMANS; HYPERPLASIA; MIDDLE AGED; POLYPS; RETROSPECTIVE STUDIES; TAMOXIFEN;

EID: 2842587111     PISSN: 10814442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomized trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 1992;339:1-15.
2. Gottardis MM, Robinson SP, Satyaswaroop PG, Jordan VC. Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse. Cancer Res 1988;48:812-815.
3. Andersson M, Storm HH, Mouridsen HT. Incidence of new primary cancers after adjuvant tamoxifen therapy and radiotherapy for early breast cancer. J Natl Cancer Inst 1991;83:1013-1017.
4. Killackey MA, Hakes TB, Pierce VK. Endometrial adenocarcinoma in breast cancer patients receiving antiestrogens. Cancer Treat Rep 1985;69:237-238.
5. Hardell L. Tamoxifen as risk factor for carcinoma of corpus uteri [letter]. Lancet 1988;2:563.
6. Hardell L. Pelvic irradiation and tamoxifen as risk factors for carcinoma of corpus uteri [letter]. Lancet 1988;2:1432.
7. Neven P, De Muylder X, Van Belle Y, Vanderick G, De Muylder E. Tamoxifen and the uterus and endometrium [letter]. Lancet 1989;1:375.
8. Atlante G, Pozzi M, Vincenzoni C, Vocaturo G. Four case reports presenting new acquisitions on the association between breast and endometrial carcinoma. Gynecol Oncol 1990;37:378-380.
9. Mathew A, Chabon AB, Kabakow B, Drucker M, Hirschman RJ. Endometrial carcinoma in five patients with breast cancer on tamoxifen therapy. NY State J Med 1990;90:207-208.
10. Malfetano JH. Tamoxifen-associated endometrial carcinoma in postmenopausal breast cancer patients. Gynecol Oncol 1990;39:82-84.
11. Magriples U, Naftolin F, Schwartz PE, Carcangiu ML. High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients. J Clin Oncol 1993;11:485-490.
12. Lahti E, Blanco G, Kauppila A, Apaja-Sarkkinen M, Taskinen PJ, Laatikainen T. Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen. Obstet Gynecol 1993;81:660-664.
13. Seoud MA, Johnson J, Weed JC, Jr. Gynecologic tumors in tamoxifen-treated women with breast cancer. Obstet Gynecol 1993;82:165-169.
14. Fornander T, Rutqvist LE, Cedermark B et al. Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers. Lancet 1989;1:117-120.
15. Fisher B, Costantino JP, Redmond CK, Fisher ER, Wickerham L, Cronin WM. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst 1994;86:527-537.
16. Satyaswaroop PG, Zaino RJ, Mortel R. Estrogen-like effects of tamoxifen on human endometrial carcinoma transplanted into nude mice. Cancer Res 1984;44:4006-4010.
17. Sunderland MC, Osborne CK. Tamoxifen in premenopausal patients with metastatic breast cancer: a review. J Clin Oncol 1991;9:1283-1297.
18. Gal D, Kopel S, Bashevkin M, Lebowicz J, Lev R, Tancer ML. Oncogenic potential of tamoxifen on endometria of postmenopausal women with breast cancer - preliminary report. Gynecol Oncol 1991;42:120-123.
19. Wolf DM, Jordan VC. Gynecologic complications associated with long-term adjuvant tamoxifen therapy for breast cancer. Gynecol Oncol 1992;45:118-128.
20. Hacker NF, Moore JG, eds. Essentials of Obstetrics and Gynecology. 2nd ed. Philadelphia: W.B. Saunders, 1992:577.
21. Lahti E, Blanco G, Kauppila A et al. Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen. Obstet Gynecol 1993;81:660-664.